ONCAlert | 2018 SGO Annual Meeting on Women’s Cancer

Chemotherapy-Induced Nausea and Vomiting: Emerging Therapies and New Guidelines

This activity is supported by an educational grant from Eisai, Inc.
Published Online:10:56 AM, Wed July 23, 2014
This activity is supported by an educational grant from Eisai, Inc.

Diagnosing and Treating Chemotherapy-Induced Nausea and Vomiting: Understanding the Need and Clinical Data for Best Patient Care
Hope S. Rugo, MD
Professor of Medicine
Director, Breast Oncology Clinical Trials Education
Department of Medicine, Division of Hematology/Oncology
University of California San Francisco Medical Center
San Francisco, California


Current Clinical Practice for Chemotherapy-Induced Nausea and Vomiting: Understanding the Up-to-Date Evidence-Based Guidelines for Prevention and Treatment
Una Hopkins, RN, DNP
Assistant Professor, New York University Nursing
Administrative Director, White Plains Hospital Cancer Center
White Plains, New York


Contributing Editorial Support
Anna Azyolinsky, PhD
Medical Consultant
New York, New York


Beatriz Manzor Mitrzyk, PharmD, BCPS
Medical Consultant
Northville, Michigan


Activity Overview
This activity is designed to educate oncologists and oncology nurses on the optimal management of chemotherapy-induced nausea and vomiting (CINV), education on the efficacy and safety data for current and emerging agents for the treatment of CINV, and current guidelines for management of CINV.

To continue this CME, click here.
Publications
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.